Citation: | SUN Xin-yi, MIAO Jun-jun, GE Jin. The Effect of Yinjia Pellet on the Short Term Efficacy and Long Term Recurrence Rate of Treating Graves' Hyperthyroidism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 356-359. doi: 10.14148/j.issn.1672-0482.2021.0356 |
[1] |
王吉耀. 内科学[M]. 北京: 人民卫生出版社, 2005: 880-891.
|
[2] |
ABRAHAM P, AVENELL A, MCGEOCH SC, et al. Antithyroid drug regimen for treating Graves' hyperthyroidism[J]. Cochrane Database Syst Rev, 2010(1): CD003420.
|
[3] |
SUNDARESH V, BRITO JP, WANG Z, et al. Comparative effectiveness of therapies for Graves' hyperthyroidism: A systematic review and network meta-analysis[J]. J Clin Endocrinol Metab, 2013, 98(9): 3671-3677. doi: 10.1210/jc.2013-1954
|
[4] |
邓云, 彭嵘, 杨丽娟, 等. 中西医结合治疗Graves病近远期疗效及安全性[J]. 长春中医药大学学报, 2014, 30(2): 300-302. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201402043.htm
|
[5] |
中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南: 甲状腺功能亢进症[J]. 中华内科杂志, 2007, 46(10): 876-882. doi: 10.3760/j.issn:0578-1426.2007.10.035
|
[6] |
中药新药临床研究指导原则[S]. 北京: 中国医药科技出版社, 2002.
|
[7] |
WERNER SC. Modification of the classification of the eye changes of Graves' disease: Recommendations of the ad hoc committee of the American thyroid association[J]. J Clin EndocrinolMetab, 1977, 44(1): 203-204. doi: 10.1210/jcem-44-1-203
|
[8] |
倪青. 甲状腺功能亢进症病证结合诊疗指南[J]. 世界中医药, 2021, 16(2): 193-196. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZA202102004.htm
|
[9] |
温小凤, 李汶珊, 吴刚强, 等. 解发良教授治疗甲状腺功能亢进症临床经验[J]. 天津中医药大学学报, 2021, 40(1): 19-22.
|